Aclaris Therapeutics, Inc.
← Back to ACRS Overview

Aclaris Therapeutics, Inc. (ACRS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-4.66

Financial Fundamentals

ACRSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-03-31-2.21
2014-06-30-2.21
2014-09-30-11.03
2014-12-31-11.28
2015-03-31-11.17
2015-06-30-20.57
2015-09-30-5.02
2015-12-31-25.48
2016-03-31-7.33
2016-06-30-7.41
2016-09-30-12.82
2016-12-31-13.83
2017-03-31-15.48
2017-06-30-12.15
2017-09-30-10.23
2017-12-31-8.29
2018-03-31-4.48
2018-06-30-4.95
2018-09-30-3.53
2018-12-31-1.86
2019-03-31-1.67
2019-06-30-0.50
2019-09-30-0.20
2019-12-31-1.05
2020-03-31-0.69
2020-06-30-1.47
2020-09-30-2.58
2020-12-31-5.22
2021-03-31-11.03
2021-06-30-13.05
2021-09-30-13.03
2021-12-31-9.76
2022-03-31-14.09
2022-06-30-11.22
2022-09-30-13.15
2022-12-31-9.50
2023-03-31-4.80
2023-06-30-6.19
2023-09-30-4.14
2023-12-31-12.48
2024-03-31-1.32
2024-06-30-1.87
2024-09-30-2.71
2024-12-31-0.61
2025-03-31-3.10
2025-06-30-2.82
2025-09-30-3.99
2025-12-31-4.66

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.